Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)

Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas et al. · 2010

Read Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS) by Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012100.txt.

Description

Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas, and colleagues wrote in PLOS ONE in 2010 about an early, contained form of breast cancer. This stage, often found by screening, does not always turn invasive, yet many patients still get strong treatment because doctors cannot tell which cases are risky. The team studied a protein on the support cells that wrap each milk duct.

When those support cells die back, a tumor may break out of the duct. Tumors with low levels of the protein's gene message behaved like the high-risk kind. A marker like this could one day help doctors spare low-risk women harsh treatment while acting fast on the cases most likely to spread.

Catalog record

CREATORJérôme Toussaint, Virginie Durbecq, Sevilay Altintas et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012100

Browse the full library · About the Tower of Babel